Latest Updates and Innovations: 
News & Videos

We keep you informed with the latest breakthroughs, updates, and stories from Cercare Medical. Dive into our articles to discover how we're pushing the boundaries of perfusion imaging, learn about our recent projects, and hear from the experts leading the way. Stay connected with the innovations and insights shaping the future of medical imaging.

Recent Posts

Basel, Switzerland

MAY 15th.-17th. , 2024
BOOTH N° B11

Leif Østergaard
Scientific board member

Perfusion Summit 2027

Perfusion Summit 2027

15/06/2026
Perfusion Summit 2027! Bringing Together the Global Perfusion Imaging Community Now entering its fourth year, Perfusion Summit continues…
Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation

Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation

25/06/2026
PRESS RELEASE Cercare Medical Receives FDA 510(k) Clearance for AI-Powered Brain Tumor Segmentation Oncology Virtual Expert Enables Semi-Automated, On-Premise Tumor Segmentation for Neuro-Oncology Teams Across North America AARHUS, DENMARK, 25 June 2026: Cercare Medical, a leader in advanced neuroimaging software, today announced FDA 510(k) clearance (K260316) for its Oncology Virtual Expert, an AI-powered brain tumor […]
Read
Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion

Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion

28/05/2026
PRESS RELEASE Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion Enabling Real-Time Tissue Assessment Directly in the Angio Suite for Acute Stroke Patients. AARHUS, DENMARK, 28 May 2026: Cercare Medical, a leader in advanced neuroimaging software, today announced FDA 510(k) clearance (K253831) for its Cone-Beam CT (CBCT) Perfusion solution, enabling qualitative perfusion assessment […]
Read
Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment

27/05/2026
PRESS RELEASE Siemens Healthineers and Cercare Medical Announce Global Collaboration on Cone-Beam CT Perfusion Guided Stroke Treatment AARHUS, DENMARK / FORCHHEIM, GERMANY, 27 May 2026: Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patients Collaboration supports the vision of angio-only approach for precise and timely stroke […]
Read
Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows

Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows

06/02/2026
PRESS RELEASE Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows Latest release introduces AI-powered brain masking, improved PACS integration, and enhanced tumor and perfusion workflows. AARHUS, DENMARK, 6 February 2026: Cercare Medical, a leader in advanced neuroimaging software, today announces the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 18. The new […]
Read
Cercare Medical Showcases Breakthrough CBCT Perfusion Technology at RSNA 2025

Cercare Medical Showcases Breakthrough CBCT Perfusion Technology at RSNA 2025

28/11/2025
PRESS RELEASE Cercare Medical Showcases Breakthrough CBCT Perfusion Technology at RSNA 2025 Bringing Advanced Perfusion Imaging Into the Angio Suite to Transform Stroke and Oncology Care CHICAGO, IL, 28 Nov 2025: Cercare Medical will unveil its latest innovation - CBCT Perfusion - at RSNA 2025, held November 30 to December 4 at McCormick Place in Chicago. […]
Read
Cercare Medical Successfully Meets DTAC Requirements

Cercare Medical Successfully Meets DTAC Requirements

24/11/2025
NEWS Cercare Medical Successfully Meets DTAC Requirements Cercare Medical is pleased to announce that our Cercare Medical Neurosuite platform has been independently assessed by a recognised 3rd party assessor to be fully compliant with the UK NHS Digital Technology Assessment Criteria (DTAC).The Digital Technology Assessment Criteria (DTAC) is the UK National Health Service’s standard for evaluating […]
Read
Cercare Medical Selected for Nationwide Hospital Rollout in Norway

Cercare Medical Selected for Nationwide Hospital Rollout in Norway

24/06/2025
PRESS RELEASE Cercare Medical Selected for Nationwide Hospital Rollout in Norway Advanced Perfusion Imaging Software to Support Stroke and Oncology Diagnostics in Every Public Hospital. AARHUS, DENMARK, 23 June 2025: Cercare Medical is proud to announce its successful selection in the Norwegian National Tender for advanced imaging software. This award secures Cercare Medical’s installation across every […]
Read
Cercare Medical Secures Additional Regulatory Clearance in South Korea

Cercare Medical Secures Additional Regulatory Clearance in South Korea

06/06/2025
Cercare Medical Secures Additional Regulatory Clearance in South Korea Milestone approval and new partnership reinforce Cercare Medical’s strategic expansion across key Asian markets. AARHUS, DENMARK, 6 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is pleased to announce it has received additional regulatory clearance in South Korea for its Cercare Medical Neurosuite with […]
Read
Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging

Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging

04/06/2025
PRESS RELEASE Cercare Medical Releases Version 17 of Neurosuite: Advancing Precision and Efficiency in Neuroimaging Latest update includes new, improved tools for more precise tumor assessment and stroke care. AARHUS, DENMARK, 4 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is proud to announce the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 17. […]
Read
Perfusion Summit 2027

Perfusion Summit 2027

15/06/2026
Perfusion Summit 2027! Bringing Together the Global Perfusion Imaging Community Now entering its fourth year, Perfusion Summit continues…
Perfusion Summit 2026

Perfusion Summit 2026

12/08/2025
Summit/2603 Dinner/2603 Morning/2703 Afternoon/2703 Poster/2703 Presentations The 3rd Perfusion Summit Is ON — See You in Paris! Cercare…

Tab Content

This is a basic text element.

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
Contact us
Cercare Medical A/S
Inge Lehmanns Gade 10
8000 Aarhus C
Denmark

Solutions
Cercare Perfusion Neuro & Oncology Stroke Modules
Support
Assistance Instructions for Use Distributor Portal
Company
Board Members Investors About News Career Privacy Policy Regulatory & Compliance
© 2026 Cercare Medical. All rights reserved.
TRY US

CLINICAL USE CASES AND TECHNICAL HIGHLIGHTS


CLINICAL USE CASES
  • Directly impacts the patient treatment pathway, both intra- and post-intervention.
  • Assess outcomes post-intervention: detect missed stenoses, distal occlusions, or microvascular disturbances.
  • Guide complementary therapies on the spot based on perfusion status.
  • May detect the no-reflow phenomenon — providing insight into cases where recovery may fail despite successful thrombectomy.
  • Potentially enables direct-to-angio workflows.

TECHNICAL HIGHLIGHTS
  • Full set of perfusion markers: CBF, CBV, MTT.
  • Advanced oxygen metabolism imaging: OEF, CMRO₂.
  • Most reliable results with 10 CBCT acquisitions.
  • Vendor-agnostic platform.

CBCT Imaging

Side-by-side comparison: The left-hand side is the raw CBCT data, while the right-hand side panel is the pre-processed data.
Using CMN software in the angio suite delivers results comparable to conventional CT/MR perfusion.

Contact us:

A Cercare Medical Representative will reach out to you directly to assist with your inquiry.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)

Imaging

MTT

SVD model

MTT

Vascular Model

T2 FLAIR

follow-up image
Perfusion maps of a stroke patient show a large difference in lesion appearance compared to the SVD technique, where the VM appears in better correspondence with the T2 FLAIR follow-up.

MTT

SVD model

MTT

Vascular Model

T2 FLAIR

follow-up image
The modest degree of tissue involvement is consistent with the
moderate neurologic deficits, National Institutes of Health Stroke
Scale (NIHSS) = 4.

Thank you for uploading your DICOM files.

Your submission has been received successfully.

Next steps:

  • Our team will analyze the uploaded data.
  • A Cercare Medical representative will reach out to you once the analysis is complete.
  • Rest assured that all files will be deleted immediately after use, in line with our data protection policies.

Request a Demo

Let us give you a tour around our solution.

Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.
})